# Comparison Study of Insulin Glargine and NPH Insulin

> **NCT01854723** · PHASE4 · WITHDRAWN · sponsor: **Providence Health & Services**

## Conditions studied

- Diabetes

## Interventions

- **DRUG:** Switching to NPH insulin
- **DRUG:** Continuation of insulin glargine

## Key facts

- **NCT ID:** NCT01854723
- **Lead sponsor:** Providence Health & Services
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-04
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2020-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01854723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01854723, "Comparison Study of Insulin Glargine and NPH Insulin". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT01854723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*